In an effort to encourage more blood donations, the Food and Drug Administration today said it is revisiting and updating several existing policies to help ensure an adequate-but-safe national blood supply.

To account for COVID-19, the agency is providing notice of alternatives to certain blood donor eligibility requirements for the duration of the pandemic. Among other changes, the guidance allows blood centers to reduce donation deferral periods for certain categories of blood donors from 12 months to three. FDA said it will provide notification when the alternative procedures are no longer in effect.

FDA also issued the following:

According to the agency, these recommendations are expected to remain in place after the COVID-19 pandemic ends, with any appropriate changes based on comments FDA receives.

Related News Articles

Headline
The Centers for Disease Control and Prevention updated its page on COVID-19 transmission to clarify other types of spread beyond person to person, such as by…
Headline
The Food and Drug Administration yesterday updated guidance to spur wider availability of alcohol-based hand sanitizers during the COVID-19 pandemic. The…
Headline
The Health Resources and Services Administration today awarded $20.3 million to increase the number of fellows at accredited addiction medicine and addiction…
Headline
The Centers for Medicare & Medicaid Services yesterday implemented several new infection control actions to combat COVID-19 in nursing homes. One…
Headline
The AHA today asked the Department of Health and Human Services to distribute substantial additional emergency funds to hospitals and health systems in an…
Headline
An estimated 9.5% of U.S. residents, or 30.7 million people, lacked health insurance when surveyed in the first six months of 2019, according to preliminary…